Lilian Mazza

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Discontinuing vs continuing ACEIs and ARBs in hospitalized patients with COVID-19 according to disease severity: Insights from the BRACE CORONA trial”.

Discontinuing vs continuing ACEIs and ARBs in hospitalized patients with COVID-19 according to disease severity: Insights from the BRACE CORONA trial

American Heart Journal(2022)10.1016/j.ahj.2022.04.001

N/A

1.1DataRank · unranked

19 citations

Pedro Gabriel Melo de Barros e Silva, Thiago Ceccatto de Paula, Renata Moll‐Bernardes, Tiago Mendonça dos Santos, Lilian Mazza +10 more

Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial

American Heart Journal(2020)10.1016/j.ahj.2020.05.002

N/A

0DataRank · unranked

144 citations

Ariane Vieira Scarlatelli Macedo, Pedro Gabriel Melo de Barros e Silva, Renata Moll‐Bernardes, André Feldman, Guilherme Arruda +10 more